XWELL Return on Tangible Equity 2010-2024 | XWEL
Current and historical return on tangible equity values for XWELL (XWEL) over the last 10 years. Return on tangible equity can be defined as the amount of net income returned as a percentage of shareholders equity, after subtracting intangible assets, goodwill and preferred equity.
| XWELL Return On Tangible Equity Historical Data | |||
|---|---|---|---|
| Date | TTM Net Income | Tangible Equity | Return on Tangible Equity |
| 2024-09-30 | $-0.02B | $0.01B | -98.36% |
| 2024-06-30 | $-0.02B | $0.02B | -118.92% |
| 2024-03-31 | $-0.03B | $0.02B | -118.18% |
| 2023-12-31 | $-0.03B | $0.02B | -108.41% |
| 2023-09-30 | $-0.04B | $0.03B | -114.73% |
| 2023-06-30 | $-0.03B | $0.03B | -81.53% |
| 2023-03-31 | $-0.03B | $0.04B | -68.34% |
| 2022-12-31 | $-0.03B | $0.04B | -52.89% |
| 2022-09-30 | $-0.02B | $0.05B | -21.48% |
| 2022-06-30 | $-0.00B | $0.07B | -3.47% |
| 2022-03-31 | $0.00B | $0.08B | 1.09% |
| 2021-12-31 | $0.00B | $0.10B | 4.15% |
| 2021-09-30 | $-0.01B | $0.10B | -15.14% |
| 2021-06-30 | $-0.03B | $0.09B | -32.30% |
| 2021-03-31 | $-0.08B | $0.10B | -127.56% |
| 2020-12-31 | $-0.09B | $0.08B | -247.62% |
| 2020-09-30 | $-0.08B | $0.05B | -572.41% |
| 2020-06-30 | $-0.08B | $0.02B | -16400.00% |
| 2020-03-31 | $-0.03B | $-0.01B | 527.27% |
| 2019-12-31 | $-0.02B | $-0.01B | 840.00% |
| 2019-09-30 | $-0.02B | $-0.00B | -2800.00% |
| 2019-06-30 | $-0.02B | $0.00B | -633.33% |
| 2019-03-31 | $-0.02B | $0.00B | -340.00% |
| 2018-12-31 | $-0.04B | $0.00B | -524.14% |
| 2018-09-30 | $-0.04B | $0.01B | -420.00% |
| 2018-06-30 | $-0.04B | $0.01B | -352.00% |
| 2018-03-31 | $-0.05B | $0.01B | -341.82% |
| 2017-12-31 | $-0.03B | $0.02B | -190.16% |
| 2017-09-30 | $-0.02B | $0.02B | -115.79% |
| 2017-06-30 | $-0.02B | $0.01B | -111.39% |
| 2017-03-31 | $-0.03B | $0.02B | -119.54% |
| 2016-12-31 | $-0.02B | $0.03B | -107.87% |
| 2016-09-30 | $-0.00B | $0.02B | -20.51% |
| 2016-06-30 | $-0.01B | $0.02B | -72.13% |
| 2016-03-31 | $-0.01B | $0.02B | -81.82% |
| 2015-12-31 | $-0.01B | $0.02B | -141.18% |
| 2015-09-30 | $-0.10B | $0.00B | -1434.48% |
| 2015-06-30 | $-0.10B | $0.00B | -866.67% |
| 2015-03-31 | $-0.11B | $0.01B | -583.33% |
| 2014-12-31 | $-0.11B | $0.01B | -512.94% |
| 2014-09-30 | $-0.05B | $0.02B | -214.43% |
| 2014-06-30 | $-0.05B | $0.03B | -185.45% |
| 2014-03-31 | $-0.05B | $0.02B | -173.33% |
| 2013-12-31 | $-0.05B | $0.03B | -152.52% |
| 2013-09-30 | $-0.05B | $0.03B | -119.25% |
| 2013-06-30 | $-0.04B | $0.04B | -141.59% |
| 2013-03-31 | $-0.03B | $0.04B | -167.57% |
| 2012-12-31 | $-0.02B | $0.05B | -247.06% |
| 2012-09-30 | $-0.01B | $-0.01B | 200.00% |
| 2012-06-30 | $-0.00B | $-0.00B | 1600.00% |
| 2012-03-31 | $-0.00B | $0.00B | 800.00% |
| 2011-12-31 | $-0.00B | $0.00B | 300.00% |
| 2011-09-30 | $-0.01B | $-0.00B | 333.33% |
| 2011-06-30 | $-0.01B | $-0.00B | 933.33% |
| 2011-03-31 | $-0.01B | $-0.00B | -2000.00% |
| 2010-12-31 | $-0.01B | $0.00B | -1466.67% |
| 2010-06-30 | $-0.01B | $0.00B | -1066.67% |
| 2010-03-31 | $-0.00B | inf% | |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Services | $0.007B | $0.030B |
| XWELL Inc. is a health and wellness holding company. Its operating brands include XpresCheck(R), XpresSpa(R), Treat(TM) and HyperPointe. XpresSpa is a retailer of wellness services and related products. Treat is a travel health and wellness brand. XpresCheck is a provider of Covid-19 screening and diagnostic testing in partnership with the CDC and Concentric by Ginkgo. HyperPointe is a digital healthcare and data analytics relationship company. XWELL Inc., formerly known as XpresSpa Group Inc., is based in NEW YORK. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Elevance Health (ELV) | United States | $92.839B | 12.14 |
| Cencora (COR) | United States | $49.468B | 18.60 |
| DiDi Global (DIDIY) | China | $22.650B | 0.00 |
| Natera (NTRA) | United States | $22.209B | 0.00 |
| ICON (ICLR) | Ireland | $16.344B | 14.56 |
| Revvity (RVTY) | United States | $15.033B | 26.11 |
| Avantor (AVTR) | United States | $14.626B | 21.93 |
| BioMerieux (BMXMF) | France | $14.203B | 0.00 |
| Viatris (VTRS) | United States | $13.523B | 4.17 |
| CochLear (CHEOY) | Australia | $12.916B | 0.00 |
| Solventum (SOLV) | United States | $12.870B | 0.00 |
| Doximity (DOCS) | United States | $10.767B | 63.37 |
| Medpace Holdings (MEDP) | United States | $10.662B | 30.04 |
| EUROFINS SCIENT (ERFSF) | Luxembourg | $10.135B | 0.00 |
| HealthEquity (HQY) | United States | $9.429B | 47.30 |
| Sonic Healthcare (SKHHY) | Australia | $8.657B | 0.00 |
| Charles River Laboratories (CRL) | United States | $8.266B | 15.97 |
| Bausch + Lomb (BLCO) | Canada | $6.301B | 29.31 |
| Amplifon S.p.A (AMFPF) | Italy | $6.136B | 31.28 |
| BrightSpring Health Services (BTSG) | United States | $4.136B | 87.96 |
| Organon (OGN) | United States | $4.079B | 4.11 |
| Sotera Health (SHC) | United States | $3.875B | 20.73 |
| Surgery Partners (SGRY) | United States | $3.273B | 37.32 |
| Concentras Parent (CON) | United States | $2.998B | 0.00 |
| Alignment Healthcare (ALHC) | United States | $2.937B | 0.00 |
| Premier (PINC) | United States | $2.191B | 11.40 |
| Ardent Health Partners (ARDT) | United States | $2.098B | 0.00 |
| PACS (PACS) | United States | $2.080B | 0.00 |
| GeneDx Holdings (WGS) | United States | $2.079B | 0.00 |
| Progyny (PGNY) | United States | $1.980B | 40.09 |
| GoodRx Holdings (GDRX) | United States | $1.845B | 48.40 |
| Teladoc Health (TDOC) | United States | $1.782B | 0.00 |
| Agilon Health (AGL) | United States | $1.413B | 0.00 |
| Ryman Healthcare (RYHTY) | New Zealand | $1.409B | 0.00 |
| Pediatrix Medical (MD) | United States | $1.219B | 11.92 |
| CareDx (CDNA) | United States | $1.210B | 0.00 |
| Embecta (EMBC) | United States | $1.070B | 7.48 |
| AMN Healthcare Services Inc (AMN) | United States | $1.036B | 7.02 |
| Establishment Labs Holdings (ESTA) | $0.947B | 0.00 | |
| Auna S.A (AUNA) | Luxembourg | $0.637B | 0.00 |
| SBC Medicals (SBC) | United States | $0.518B | 0.00 |
| InnovAge Holding (INNV) | United States | $0.505B | 0.00 |
| DocGo (DCGO) | United States | $0.490B | 18.46 |
| QDM (QDMI) | Hong Kong, SAR China | $0.480B | 12.56 |
| Sonida Senior Living (SNDA) | United States | $0.451B | 0.00 |
| Enhabit (EHAB) | United States | $0.422B | 36.52 |
| COMPASS Pathways (CMPS) | United Kingdom | $0.280B | 0.00 |
| MultiPlan (MPLN) | United States | $0.267B | 0.00 |
| LifeMD (LFMD) | United States | $0.248B | 0.00 |
| Nutex Health (NUTX) | United States | $0.243B | 0.00 |
| Sera Prognostics (SERA) | United States | $0.212B | 0.00 |
| Beauty Health (SKIN) | United States | $0.205B | 0.00 |
| Performant Healthcare (PHLT) | United States | $0.184B | 0.00 |
| Biodesix (BDSX) | United States | $0.151B | 0.00 |
| So-Young (SY) | China | $0.105B | 17.83 |
| Ascend Wellness Holdings (AAWH) | United States | $0.079B | 0.00 |
| IceCure Medical (ICCM) | Israel | $0.068B | 0.00 |
| ModivCare (MODV) | United States | $0.066B | 3.57 |
| Oncology Institute (TOI) | United States | $0.063B | 0.00 |
| NeueHealth (NEUE) | United States | $0.061B | 1.61 |
| Singular Genomics Systems (OMIC) | United States | $0.050B | 0.00 |
| NeuroOne Medical Technologies (NMTC) | United States | $0.038B | 0.00 |
| OncoCyte (OCX) | United States | $0.034B | 0.00 |
| Co-Diagnostics (CODX) | United States | $0.025B | 0.00 |
| Pheton Holdings (PTHL) | China | $0.024B | 0.00 |
| KindlyMD (KDLY) | United States | $0.008B | 0.00 |
| SeaStar Medical Holding (ICU) | United States | $0.008B | 0.00 |
| BioNexus Gene Lab (BGLC) | $0.007B | 0.00 | |
| Intelligent Bio Solutions (INBS) | United States | $0.006B | 0.00 |
| NewGenIvf Group (NIVF) | Thailand | $0.003B | 0.00 |
| ISpecimen (ISPC) | United States | $0.002B | 0.00 |
| Aclarion (ACON) | United States | $0.001B | 0.00 |
| Cano Health (CANOQ) | United States | $0.000B | 0.00 |